PYPD Rasio cepet PolyPid Ltd

PolyPid Ltd. (PYPD) is competing for the hospital sector amid intense pressure from global medical supply providers. Meanwhile, demand in surgery is rising as clinics seek to reduce readmission costs. The company relies on the D-PLEX platform, which ensures high margins through the mass production of antibacterial gels. The current ratio is 1.11, a figure clearly demonstrated by the price history on the GURU.Markets chart.

The use of third-party contractors for production and logistics reduces the burden on PolyPid Ltd. (PYPD) warehouses, rendering cash and accounts receivable the primary assets. By analyzing the final quick ratio, an investor assesses the company's ability to meet short-term obligations without relying on inventories, determining the balance between financial stability and working capital efficiency.